GenePOC will participate in the 27th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) from April 22 to 25, in Vienna, Austria. Come visit our booth #67, and discover the new revogene system for cost-effective, rapid, and accurate molecular detection of infectious diseases at Point-of-Care. Click here for more information about ECCMID.
Click here to read the article.
GenePOC will attend the ASM Microbe 2016 Conference from June 16 to 20, held in Boston, Massachusetts. Join us in booth 1628.
GenePOC Inc., a Canadian company developing cost-effective and rapid molecular devices to detect pathogen genes at Point-of-Care, is pleased to announce that its project, in partnership with Université Laval, was successful in securing funding from Genome Canada and Génome Québec through the Genomic Applications Partnership Program (GAPP). The project, entitled “New test to rapidly diagnose infections”, aims to […]
Québec City, February 2, 2016 – GenePOC Inc. is proud to announce that it has obtained the certification ISO 13485:2003 for its Quality Management System for Medical Devices. Click here for the press release.